Boehringer Ingelheim Pharma GmbH and Co. KG [Ingelheim Am Rhein / Germany]

Boehringer Ingelheim Pharma GmbH and Co. KG [Ingelheim Am Rhein / Germany] located in INGELHEIM AM RHEIN RHINELAND-PALATINATE, Germany under the [Boehringer Ingelheim] organization had its last known inspection on 13 Oct 2022. There are 22 known inspections on record.

Site Details

Industries:
Human Drugs, Animal Health, Medical Devices
Tags:
FDF Manufacturer, API Manufacturer, Human Drugs, Packaging, Analytical Testing, Manufacturer, Label, Animal Health, Medical Devices, Animal Health: Animal Drugs
Parent Organization:
Boehringer Ingelheim
Last Inspection Date:
13 Oct 2022
FEI:
3002806556
Redica ID:

Boehringer Ingelheim Pharma GmbH and Co. KG [Ingelheim Am Rhein / Germany]'s Most Recent Documents

Publish Date Document Type Title
May, 2018 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2018-05-04
March, 2016 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2016-03-08
March, 2016 EIR Boehringer Ingelheim Pharma GmbH and Co. KG - EIR, 2016-03-08
March, 2014 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2014-03-07
November, 2012 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2012-11-12

Experience Redica Systems’s NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more